Yeasty does it

BiocipherX Inc. could accelerate drug discovery with a platform that weds yeast-based phenotypic screening with AI to characterize the mechanism of action of novel small molecules.

While high throughput genetic screens are widely used to rapidly quantify the effect of a genetic mutation on a given phenotype, their use is limited to mutations that affect cell growth...